Ketamine patient John Cosgrove pleads for Southern DHB to continue its ketamine trial. Ketamine — a tranquillising drug which can also abused recreationally — is a controversial potential treatment for depression and anxiety disorders. Dr Strong said the ketamine trial was the only one of its kind in New Zealand, and it had always been under review. However, the programme had been a trial and results had shown that for long-term treatment, ketamine did not seem to work very well. "Perhaps, one day, ketamine will be part of robust treatment plans for our patients.

Source: Otago Daily Times February 16, 2018 15:56 UTC